학술논문
Brentuximab Vedotin Plus Doxorubicin, Vinblastine, Dacarbazine (A+AVD) As Frontline Therapy Demonstrates Superior Modified Progression-Free Survival Versus ABVD in Patients with Previously Untreated Stage III or IV Hodgkin Lymphoma (HL): The Phase 3 Echelon-1 Study
Document Type
Abstract
Author
Connors, Joseph M; Jurczak, Wojciech; Straus, David J.; Ansell, Stephen M; Kim, Won Seog ; Gallamini, Andrea ; Younes, Anas; Alekseev, Sergei; Illes, Arpad ; Picardi, Marco ; Lech-Maranda, Ewa ; Oki, Yasuhiro; Feldman, Tatyana A; Smolewski, Piotr ; Savage, Kerry J; Bartlett, Nancy L.; Walewski, Jan; Chen, Robert W.; Ramchandren, Rod; Zinzani, Pier Luigi; Cunningham, David ; Heo, Dae Seog ; Rosta, Andras ; Josephson, Neil; Ruffner, Katherine L.; Sachs, Jessica ; Liu, Rachael ; Jolin, Hina ; Huebner, Dirk; Radford, John A.
Source
In Blood 8 December 2017 130 Supplement 1:6-6
Subject
Language
ISSN
0006-4971